Role of blood pressure in development of early retinopathy in adolescents with type 1 diabetes: prospective cohort study by Gallego, Patricia Herold et al.
RESEARCH
Roleof bloodpressure in development of early retinopathy
in adolescents with type 1 diabetes: prospective cohort
study
Patricia Herold Gallego, clinical research fellow in paediatric endocrinology,
1 Maria E Craig, paediatric
endocrinologist,
1,2,3 Stephen Hing, ophthalmologist,
1 Kim C Donaghue, paediatric endocrinologist
1,2
ABSTRACT
ObjectiveToexaminetherelationbetweenbloodpressure
and the development of early retinopathy in adolescents
with childhood onset type 1 diabetes.
Design Prospective cohort study.
Setting Diabetes Complications Assessment Service at
the Children’s Hospital at Westmead, Sydney, Australia.
Participants 1869 patients with type 1 diabetes (54%
female) screened for retinopathy with baseline median
age 13.4 (interquartile range 12.0-15.2) years, duration
4.9(3.1-7.0)years,andalbuminexcretionrateof4.4(3.1-
6.8)μg/minplusasubgroupof1093patientsretinopathy-
free at baseline and followed for a median 4.1 (2.4-6.6)
years.
Main outcome measures Early background retinopathy;
blood pressure.
Results Overall, retinopathy developed in 673 (36%)
participants at any time point. In the retinopathy-free
group, higher systolic blood pressure (odds ratio 1.01,
95% confidence interval 1.003 to 1.02) and diastolic
blood pressure (1.01, 1.002 to 1.03) were predictors of
retinopathy, after adjustment for albumin excretion rate
(1.27,1.13to1.42),haemoglobinA1c(1.08,1.02to1.15),
duration of diabetes (1.16, 1.13 to 1.19), age (1.13, 1.08
to 1.17), and height(0.98, 0.97to 0.99).In a subgroupof
1025 patients with albumin excretion rate below 7.5 μg/
min, the cumulative risk of retinopathy at 10 years’
duration of diabetes was higher for those with systolic
blood pressure on or above the 90th centile compared
with those below the 90th centile (58% v 35%, P=0.03).
The risk was also higher for patients with diastolic blood
pressure on or above the 90th centile compared with
those below the 90th centile (57% v 35%, P=0.005).
Conclusions Both systolic and diastolic blood pressure
are predictors of retinopathy and increase the probability
of early retinopathy independently of incipient
nephropathy in young patients with type 1 diabetes.
INTRODUCTION
Diabetic retinopathy affects most patients with type 1
diabetes after 15 years’ duration,
12 although more
recent data indicate a reduction in incidence of
retinopathy.
3-5 Retinopathy is common in young
patients with diabetes: in a population based study
from Australia, 24% of children and adolescents with
type1diabeteshadearlybackgroundretinopathyafter
only six years’ duration of diabetes,
6 and retinopathy
was present in 27% of Swedish patients after 13 years’
duration.
7
In addition to hyperglycaemia, hypertension has
emergedasariskfactorfordiabeticretinopathyandits
progression in adults.
8-10 Hyperglycaemia may assert
its main effect by impairing autoregulation of retinal
perfusion, thereby leaving the eye unprotected from
systemic hypertension.
11 Indeed, retinal blood flow is
higher in patients with diabetic retinopathy than in
patients without retinopathy and controls without
diabetes.
12 Furthermore, retinal arteriolar dilatation
may be the first sign of retinopathy in young patients
with type 1 diabetes.
13
Retinopathy and nephropathy often coexist in
patients with diabetes, so elevation of blood pressure
may be due to nephropathy rather than essential
hypertension. Normotensive patients with type 1
diabetes and nephropathy have worse retinal changes
than hypertensive patients with normoalbuminuria,
14
but whether blood pressure acts independently or in
association with nephropathy in the development of
retinopathyisunclear.Hypertensionisanindependent
predictor of diabetic retinopathy in all clinical
studies.
14-17 Moreover, great variability exists in the
evidence supporting the role of systolic or diastolic
blood pressure in the development of diabetic
retinopathy.
18-22 Whether the relation is continuous
or related only to a threshold effect of high blood
pressure is also unclear.
Adolescents with diabetes are an ideal group in
which to study the effect of blood pressure on the very
early development of retinopathy, because of the
absence of coexistent disease, smoking, and treatment
withotherdrugsinmostpatients.Wehypothesisedthat
bloodpressureasacontinuousvariableisapredictorof
earlydevelopmentofretinopathyandthatthisrelation
ispresentevenintheabsenceofincipientnephropathy.
Hence, we examined the association between systolic
and diastolic blood pressure and the development of
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METHODS
This study included 1869 adolescents aged under 15
(54%female)withaclinicaldiagnosisoftype1diabetes
who had retinal screening at the Diabetes Complica-
tions Assessment Service at the Children’s Hospital at
Westmead (Sydney, New South Wales, Australia)
between 1989 and 2007. We excluded patients with
secondary causes of diabetes (pancreatectomy, cystic
fibrosis, type 2 diabetes mellitus). Participants in this
study represent 45% of patients enrolled on the NSW
type1 diabetesregister
23; theydidnot differ fromnon-
participants by age, sex, or urban/rural location. All
participants gave writteninformed consent.
Screening for complications of diabetes
Wescreenedadolescentsforcomplicationsofdiabetes
according to established guidelines, which recom-
mended annual assessment beginning five years after
diagnosis (or age 11, whichever is earlier) in patients
with prepubertal onset of diabetes and two years after
diagnosis in patients with pubertal onset.
24
We assessed retinopathy by fundal photography
with a Topcon Fundus camera (TRC 50-VT, Tokyo
Optical Co, Tokyo) after dilatation of the pupils with
cyclopentolate 1% and phenylephrine 2.5%. We took
non-simultaneous photographic pairs of seven stan-
dardisedfieldsineacheyeandthenviewedthemwitha
Donaldson Stereoviewer, which provided a three
dimensional representation of the fundus and enabled
microaneurysms to be more easily distinguished from
haemorrhagesandartefacts.FromSeptember2004we
used the IMAGEnet 2000 Lite system to digitalise
images. One experienced paediatric ophthalmologist
(SH) graded the photographs according to the early
treatmentdiabeticretinopathystudy(ETDRS)adapta-
tion of the modified Airlie House classification of
diabetic retinopathy.
25 We defined retinopathy as the
presence of at least one microaneurysm or one
haemorrhage (grade 21). For use as normal controls,
we photographed 36 adolescents without diabetes; the
grader was blinded to their non-diabetic status. These
controls had no signs of microaneurysm or haemor-
rhage. We measured regrading agreement for 40
randomly selected participants (80 individual eyes)
ontwodifferentoccasions(1990-4and2001);weighted
κ values of 0.76 and 0.88 represented excellent
agreement.
26
We determined albumin excretion rate from three
consecutivetimedovernighturinespecimens.Weused
polyclonal radioimmunoassay (Pharmacia RIA, Beck-
man Coulter, Australia) to measure urinary albumin
from 1989 to March 2000. From April 2000, the
laboratory changed to nephelometric assay using an
IMMAGE analyser (IMMAGE=(0.8734×radio-
immunoassay value)−0.501; r=0.99). We defined
microalbuminuria as albumin excretion rate ≥20 and
<200 μg/min in two out of three samples. We defined
normoalbuminuria as mean albumin excretion rate
<7.5 μg/min in all urine samples.
At each complications assessment, we assessed
glycaemiccontrolbymeasuringglycatedhaemoglobin
colorimetrically
27 before February 1994 and subse-
quently by haemoglobin A1c with high performance
liquid chromatography (Diamat Bio-Rad analyser,
Bio-Rad, Herculus, CA; non-diabetic range 4-6%).
Weconvertedglycatedhaemoglobinvaluestohaemo-
globin A1c (Diamat=1.9088+0.0043×GHb; r=0.92).
The interassay coefficients of variation were 1.1% and
1.2% for values of haemoglobin A1c of 5.95% and
9.76%.
Blood pressure and other measurements
We used auscultation with a conventional mercury
sphygmomanometer device and appropriate cuff sizes
to measure systolic and diastolic blood pressure twice
in the seated position after five minutes’ rest. We used
the right arm for all measurements. We took the onset
of the first and fifth Korotkoff phases as systolic and
diastolic blood pressure. We report blood pressure
measurements in mm Hg or in Z scores after
adjustments for age and sex, as recommended in
childhood and adolescence.
28 Anthropometric data
includedheight(cm),weight(kg),andbodymassindex
(kg/m
2). We determined Z scores for body mass index
by using age and sex related reference standards.
29
Statistical analysis
We present descriptive statistics as mean and standard
deviation for normally distributed data or median and
interquartile range when distributions were skewed.
We used the χ
2 test to compare groups for categorical
variables. We evaluated differences between indepen-
dent samples by using Student’s t test if variables were
normally distributed or Mann-Whitney U test for
skewed data.
Cox proportional hazard regression and Kaplan-Meier
survival curves
We used Cox proportional hazards regression to
examine predictors of the first retinopathy event in all
Table 1 |Baselineclinicalcharacteristicsofpatientswithtype1diabetesmellitusinrelationto
developmentofretinopathyduringfollow-up.Valuesarenumber(percentage)ormedian
(interquartilerange)unlessstatedotherwise
Characteristic Noretinopathy(n=1196) Retinopathy (n=673) P value
Female 618 (51.7) 384 (57.1) 0.03
Mean (SD) age (years) 13.5 (2.34) 13.4 (2.42) 0.35
Duration of diabetes (years) 4.3 (2.9-6.2) 5.7 (3.4-8.3) <0.001
Haemoglobin A1c (%) 8.3 (7.6-9.2) 8.6 (7.8-9.5) <0.001
Albumin excretion rate (μg/min) 4.3 (3.0-6.8) 4.4 (3.3-6.8) 0.18
Systolic blood pressure (mm Hg) 110 (100-120) 110 (105-120) 0.001
Systolic blood pressure Z score 0.19 (−0.64-0.82) 0.23 (−0.25-0.91) <0.001
Diastolic blood pressure (mm Hg) 65 (60-70) 70 (60-70) <0.001
Diastolic blood pressure Z score 0.26 (−0.35-0.81) 0.43 (−0.21-0.91) <0.001
Body mass index (kg/m
2) 21 (18.8-23.8)) 20.3 (18.6-22.9) <0.001
Body mass index (Z score) 0.67 (0.11-1.20) 0.48 (−0.01-1.01) <0.001
Microalbuminuria 22/1055 (2.1) 13/542 (2.4) 0.72
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time variable. Covariates included were systolic and
diastolicbloodpressure(mmHg),sex,age,height(cm),
haemoglobin A1c, and BMI Z score or BMI >95th
centile (used as definition for obesity in adolescents).
30
We examined clinically relevant interaction terms
(blood pressure*age, blood pressure*sex, blood pres-
sure*age*sex, and age*sex), but they were not sig-
nificant. We included quadratic terms for systolic and
diastolicbloodpressuretotestforcurvature.Wereport
only significant results, expressed as hazard ratio and
95% confidence interval.
To exclude the effect of early elevation of albumin
excretion on the development of retinopathy, we used
Kaplan-Meier survival curves to estimate the prob-
ability of developing the first retinopathy event in
participants who had albumin excretion rate <7.5 μg/
min(n=1025).Weusedhigh-normalcutoffforsystolic
anddiastolicbloodpressure,definedasbloodpressure
on or above the 90th centile,
28 as factors and used the
log-rank test to compare survival times.
Generalised estimating equations
We did longitudinal analysis in participants who were
retinopathy-free at baseline and followed prospec-
tivelybyusinggeneralisedestimatingequationssothat
correlations between repeated measures for a given
patientcouldbetakenintoaccount.
31Inthismodel,we
examined different covariates as predictors of the
outcome variable, presence or absence of retinopathy
at any time. We used systolic and diastolic blood
pressures (mm Hg), sex, age, duration of diabetes,
haemoglobinA1c,albuminexcretionrate(expressedas
logalbuminexcretionrate),height(cm),andZscorefor
bodymassindexascovariates.Weexaminedclinically
relevantinteractionterms(asabove),buttheywerenot
significant. To test for curvature, a quadratic blood
pressure term was included in the analysis. We report
significant results as odds ratio and 95% confidence
interval.
RESULTS
Clinical characteristics
Forthewholegroup(n=1869,54%female),medianage
was13.4years(interquartilerange12.0-15.2),duration
of diabetes was 4.9 (3.1-7.0) years, albumin excretion
rate was 4.4 (3.1-6.8) μg/min, and haemoglobin A1c
was 8.4% (7.7-9.3%) at first assessment. Overall, 673
(36%) participants developed retinopathy at any time
during the follow-up. Moderate to severe non-prolif-
erative retinopathy developed in 35 participants, and
only one patient developed proliferative retinopathy
during the study.
Table 1showsbaselineclinicalcharacteristicsforthe
total cohort stratified by retinal status. We compared
participants who never developed retinopathy with
those who developed retinopathy at any stage during
the follow-up and found no difference in baseline age,
albumin excretion rate, or prevalence of microalbu-
minuria. However, systolic blood pressure, diastolic
bloodpressure,durationofdiabetes,andhaemoglobin
A1c were higher in patients who developed retino-
pathy.
In all, 1231 (66%) participants had more than one
visit, with median follow-up of 4.1 (3.1-7.2 ) years and
a median number of visits of 3 (2-5). The incidence of
retinopathywas14.5per100personyearsoffollow-up.
In this group, 138 participants had retinopathy at
baseline, of whom 50 (36%) regressed, 56 (41%) were
unchanged,and32(23%)progressedduringfollow-up.
Cox proportional hazard regression
In Cox proportional hazard regression (n=1869),
systolic blood pressure, female sex, haemoglobin
A1c, age, and body mass index above 95th centile
were significantly associated with a higher cumula-
tive risk of retinopathy (table 2). The quadratic term
for blood pressure was not significant, suggesting a
linear effect.
Among participants with albumin excretion rate
<7.5 μg/min (n=1025), the cumulative risk of retino-
pathy at 10 years’ duration of diabetes was higher for
thosewithsystolicbloodpressureonorabovethe90th
centile than for those below the 90th centile (58% v
35%,P=0.03)(fig1).Similarly,diastolicbloodpressure
on or above the 90th centile conferred a higher risk
compared with those below the 90th centile (57% v
35%, p=0.005) (fig 2).
Table 2 |ResultsofCoxproportionalhazardsregressionfor
developmentoffirsteventofretinopathy,withdurationof
diabetesastimevariable,inyoungpatientswithtype1diabetes
mellitus(n=1869)
Covariates Hazard ratio (95% CI) P value
Systolic blood pressure
(mm Hg)
1.02 (1.01 to 1.03) <0.001
Female sex 1.29 (1.10 to 1.51) 0.002
Age (years) 0.83 (0.81 to 0.85) <0.001
Haemoglobin A1c 1.06 (1.01 to 1.12) 0.02
Body mass index >95th
centile
1.34 (1.01 to 1.78) 0.04
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Fig 1 | Cumulative probability of first event of retinopathy for
each year since onset of diabetes in patients with albumin
excretionratealwaysbelow7.5μg/min(n=1025).Patientswere
grouped according to systolic blood pressure below or on/
above 90th centile
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Byusinggeneralisedestimatingequations,weanalysed
twosubgroupsofparticipants.Thefirstgroupincluded
all participants with more than one visit who were
retinopathy-freeatbaseline(n=1093).Retinopathywas
significantly associated with higher systolic and dia-
stolic blood pressure. Age, duration of diabetes,
haemoglobin A1c, height, and log albumin excretion
rate were also significant predictors of retinopathy
(model 1, table 3).
The secondgroup consistedof 594 participants with
more than one visit who were retinopathy-free at
baseline and had albumin excretion rate consistently
<7.5 μg/min. Results showed that diastolic blood
pressure, in addition to age, duration of diabetes, and
haemoglobin A1c, predicted retinopathy (model 2,
table 3). In both groups, quadratic terms for systolic
and diastolic blood pressure were not significant,
suggesting a linear rather than a threshold effect of
blood pressure as a predictor for retinopathy.
DISCUSSION
This longitudinal cohort study showed that higher
bloodpressurecontributestotheearlydevelopmentof
retinopathy in adolescents with type 1 diabetes,
independent of other known risk factors. Both systolic
and diastolic blood pressure contributed to risk of
retinopathy. Not only was the effect independent of
glycaemic control but it was independent of early
elevation of albumin excretion. This supports the
hypothesis that blood pressure acts independently,
rather than by association with nephropathy, in the
development of retinopathy. In addition, these results
suggest that the effect of blood pressure as a predictor
for retinopathy is linear rather than a threshold effect.
In the longitudinal cohort,a 10 mm Hg higher systolic
bloodpressurewasassociatedwitha3-20%higherrisk
of retinopathy; a 10 mm Hg higher diastolic blood
pressure increased the risk for retinopathy by 2-30%
after adjustments for age, sex, and albumin excretion
rate. An increase of 1% in haemoglobin A1c was
associatedwitha2-15%higherriskofretinopathy,and
anextraoneyear’sdurationofdiabeteswasassociated
with a 13-19% greater risk of retinopathy.
Prevalence of retinopathy
Overall, we reported that 36% of these patients
developed retinopathy. Some investigators have
reported a lower prevalence of retinopathy in the
youngpopulationthanwe sawin our study.Divergent
results may be explained by differences in age, sample
size, study design, and methods of screening for
retinopathy. Kernell and colleagues reported a pre-
valence of retinopathy of 14.5% in adolescents studied
cross sectionally, but retinopathy was assessed by the
less sensitive three field photography instead of seven
fundal photography, the gold standard tool for retino-
pathy screening.
32 Nordwalland colleaguesreporteda
prevalence of retinopathy of 27% in 80 children and
adolescents with type 1 diabetes mellitus aged
7-22 years despite intensive management over a
follow-up of 13 years.
7
Systolic and diastolic blood pressure and retinopathy
The strength of our study is the large cohort of young
patients followed for a median of four years, enabling
exploratory analyses of risk factors over time. The
sample consisted of adolescents who were not on any
other drugs except insulin, thereby reducing the effect
of comorbidities on risk of retinopathy. Our findings
extend the reports of the Wisconsin epidemiologic
study of diabetic retinopathy, in which higherbaseline
systolic blood pressure was associated with increased
risk of retinopathy 10 years later in the young onset
diabetes group (<30 years) and higher diastolic blood
pressure was associated with progression of retino-
pathy at 14 years.
933Macroproteinuria at baseline was
notsignificantintheirmodels,butthisisalatemeasure
of renal disease.
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Fig 2 | Cumulative probability of first event of retinopathy for
each year since onset of diabetes in patients with albumin
excretionratealwaysbelow7.5μg/min(n=1025).Patientswere
grouped according to diastolic blood pressure below or on/
above 90th centile
Table 3 |Factorsassociatedwithoccurrenceofretinopathyinadolescentswithtype1diabetes
mellituswhowereretinopathy-freeatbaseline:longitudinalanalysisusinggeneralised
estimatingequations(n=1093)
Covariates Odds ratio (95% CI) P value
Model 1*
Systolic blood pressure (mm Hg) 1.01 (1.003 to 1.02) 0.008
Diastolic blood pressure (mm Hg) 1.01 (1.002 to 1.03) 0.02
Age (years) 1.13 (1.08 to 1.17) <0.001
Duration (years) 1.16 (1.13 to 1.19) <0.001
Haemoglobin A1c 1.08 ( 1.02 to 1.15) 0.01
Log albumin excretion rate 1.27 (1.13 to 1.42) <0.001
Height (cm) 0.98 ( 0.97 to 0.99) <0.001
Model 2† †
Diastolic blood pressure (mm Hg) 1.02 (1.01 to 1.04) 0.004
Age (years) 1.12 (1.06 to 1.18) <0.001
Duration (years) 1.14 (1.09 to 1.18) <0.001
Haemoglobin A1c 1.14 (1.03 to 1.26) 0.009
*Included systolic and diastolic blood pressure measurements from patients who were retinopathy-free at
baseline (n=1093) along with other covariates.
†Included systolic and diastolic blood pressure measurements from patients who were retinopathy-free at
baseline and had albumin excretion rate consistently below 7.5 μg/min throughout follow-up (n=594).
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auscultation without a random zero machine. How-
ever,thephysicianstakingthebloodpressurewerenot
aware of the retinal status of the patients.
Blood pressure as a predictor of retinopathy in the
absence of incipient nephropathy
Our study has shown that higher diastolic blood
pressure was still an independent predictor of retino-
pathy in adolescents with albumin excretion rate
consistently below 7.5 μg/min, an earlier marker of
incipientrenaldisease.Conversely,albuminexcretion
rate also predicted development of retinopathy in the
entire cohort. Although antihypertensive agents pre-
vent the progression from normoalbuminuria to
microalbuminuria in patients with and without
hypertension,
34 whether treatment of normotensive
young patients with type 1 diabetes and normoalbu-
minuria will influence retinopathy risk is not known.
Hypertension has been implicated in the develop-
ment of diabetic retinopathy, on the basis of data from
observational studies, which have not always con-
trolled for other contributing factors. Interventional
studies with angiotensin converting enzyme inhibitors
have shown a reduction in progression of retinopathy
in adults with type 1 diabetes,
35 in the absence of
hypertension,and in type2diabetes.
3637Althoughthis
suggests that lowering of high blood pressure influ-
ences the risk of retinopathy, these drugs may have
benefits on the eye independent of their anti-
hypertensive properties, possibly by affecting local
production of angiotensin converting enzyme by
retinal vascular endothelial cells.
38
The definition of hypertension is arbitrary. In adults
with diabetes,lower targetsfor intervention have been
recommended than in the general population,
39 and
intensive blood pressure control in normotensive
patients with diabetes may slow the progression of
nephropathy and retinopathy.
3440 However, the
ADVANCE study found no significant reduction in
retinopathy at lower levels of blood pressure
elevation.
31
Conclusions
This study shows that a continuous relation exists
between blood pressure and risk of retinopathy. The
clinicalcareofadolescentswithtype1diabetesisoften
shared between specialists and general practitioners.
Thesefindingshighlighttheimportanceofcloseblood
pressure monitoring by all professionals involved in
the management of adolescents with diabetes, regard-
less of urinary albumin excretion and glycaemic
control, and indicate that lowering blood pressure,
even in patients without hypertension or microalbu-
minuria, may improve retinal outcomes in diabetes.
However, evidence for this proposal is lacking and
interventional trials are needed to test the risks and
benefits of lowering blood pressure in children and
adolescents with type 1 diabetes.
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